Log In
Print
BCIQ
Print
Print this Print this
 

HMPL-013, fruquintinib

  Manage Alerts
Collapse Summary General Information
Company Hutchison China MediTech Ltd.
DescriptionSmall molecule that selectively inhibits the tyrosine kinase activity associated with VEGF receptors
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today